Structural basis for producing selective MAP2K7 inhibitors.
Murakawa, Y., Valter, S., Barr, H., London, N., Kinoshita, T.(2020) Bioorg Med Chem Lett 30: 127546-127546
- PubMed: 32931911 
- DOI: https://doi.org/10.1016/j.bmcl.2020.127546
- Primary Citation of Related Structures:  
7CBX - PubMed Abstract: 
Mitogen-activated protein kinase kinase 7 (MAP2K7) in the c-Jun N-terminal kinase signal cascade is an attractive drug target for a variety of diseases. The selectivity of MAP2K7 inhibitors against off-target kinases is a major barrier in drug development. We report a crystal structure of MAP2K7 complexed with a potent covalent inhibitor bearing an acrylamide moiety as an electrophile, which discloses a structural basis for producing selective and potent MAP2K7 inhibitors.
Organizational Affiliation: 
Graduate School of Science, Osaka Prefecture University, Osaka 599-8531, Japan.